Martens A - Search Results

1

Diagnostic value of plasma levels of tumor necrosis factor alpha (TNF alpha) and interleukin-6 (IL-6) in newborns with sepsis.

de Bont ES, Martens A, van Raan J, Samson G, Fetter WP, Okken A, de Leij LH, Kimpen JL. de Bont ES, et al. Among authors: martens a. Acta Paediatr. 1994 Jul;83(7):696-9. doi: 10.1111/j.1651-2227.1994.tb13121.x. Acta Paediatr. 1994. PMID: 7949797 Clinical Trial.

2

Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 plasma levels in neonatal sepsis.

de Bont ES, Martens A, van Raan J, Samson G, Fetter WP, Okken A, de Leij LH. de Bont ES, et al. Among authors: martens a. Pediatr Res. 1993 Apr;33(4 Pt 1):380-3. doi: 10.1203/00006450-199304000-00013. Pediatr Res. 1993. PMID: 8479819

3

Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response.

Martens A, Janssen RA, Sleijfer DT, Heijn AA, Mulder NH, The TH, de Leij L. Martens A, et al. Br J Cancer. 1993 May;67(5):1118-21. doi: 10.1038/bjc.1993.205. Br J Cancer. 1993. PMID: 8494709 Free PMC article. Clinical Trial.

4

Phase I/II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer.

Buter J, Janssen RA, Martens A, Sleijfer DT, de Leij L, Mulder NH. Buter J, et al. Among authors: martens a. Eur J Cancer. 1993;29A(15):2108-13. doi: 10.1016/0959-8049(93)90044-g. Eur J Cancer. 1993. PMID: 8297649 Clinical Trial.

5

Low-dose regimen of interleukin-2 for metastatic renal carcinoma.

Sleijfer DT, Janssen RA, Willemse PH, Martens A, de Leij L, de Vries EG, Mulder NH. Sleijfer DT, et al. Among authors: martens a. Lancet. 1990 Jun 23;335(8704):1522-3. doi: 10.1016/0140-6736(90)93057-v. Lancet. 1990. PMID: 1972445 No abstract available.

6

Soluble interleukin 2 receptor and soluble CD8 levels in previously treated human immunodeficiency virus-negative hemophiliacs multiply transfused with a monoclonal antibody-purified factor VIII concentrate.

Smid WM, Martens A, van der Meer J, Hegge-Paping CS, Halie MR. Smid WM, et al. Among authors: martens a. Transfusion. 1997 Jan;37(1):86-9. doi: 10.1046/j.1537-2995.1997.37197176956.x. Transfusion. 1997. PMID: 9024495

7

T-cell evaluation in patients with colon cancer: dinitrochlorobenzene skin testing versus plasma levels of sIL-2r and sCD8.

Bleeker WA, de Ley L, Oeseburg HB, Martens A, Mulder NH, Hermans J, Plukker JT. Bleeker WA, et al. Among authors: martens a. Ann Surg Oncol. 1998 Apr-May;5(3):209-12. doi: 10.1007/BF02303773. Ann Surg Oncol. 1998. PMID: 9607619

8

Brief report: Autologous stem cell transplantation restores immune tolerance in experimental arthritis by renewal and modulation of the Teff cell compartment.

Delemarre EM, Roord ST, van den Broek T, Zonneveld-Huijssoon E, de Jager W, Rozemuller H, Martens AC, Broere F, Wulffraat NM, Glant TT, Prakken BJ, van Wijk F. Delemarre EM, et al. Among authors: martens ac. Arthritis Rheumatol. 2014 Feb;66(2):350-6. doi: 10.1002/art.38261. Arthritis Rheumatol. 2014. PMID: 24504807 Free PMC article.

9

LacZ staining in paraffin-embedded tissue sections.

Hendrikx PJ, Vermeulen J, Hagenbeek A, Vermey M, Martens AC. Hendrikx PJ, et al. Among authors: martens ac. J Histochem Cytochem. 1996 Nov;44(11):1323-9. doi: 10.1177/44.11.8918907. J Histochem Cytochem. 1996. PMID: 8918907

10

Amifostine (WR2721) for dose escalation in marrow-ablative treatment of leukaemia.

Martens AC, Hagenbeek A. Martens AC, et al. Eur J Cancer. 1999 Apr;35(4):634-40. doi: 10.1016/s0959-8049(98)00412-2. Eur J Cancer. 1999. PMID: 10492639

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

717 results

Search Page